With regard to placement capacity....I think you're over thinking it. I don't believe there is any reason to keep a lid on sp. I doesn't make any sense to me.
They just want the ability to conduct a placement without having to get sh approval which imho is reasonable and would be more efficient than having to go to an egm. I think they did ok with the last one for 40m.
A strategic placement to a cornerstone partner may be in the works.
LEAD PRODUCT: BTX 1503 (MODERATE TO SEVERE ACNE) - Phase 2 clinical trial, page-21
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.0¢ |
Change
-0.005(1.54%) |
Mkt cap ! $581.5M | |||
| Open | High | Low | Value | Volume |
| 32.5¢ | 33.0¢ | 32.0¢ | $1.058M | 3.280M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 147750 | 32.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.5¢ | 632850 | 6 |
View Market Depth
| Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
| BOT (ASX) Chart |